We are live on ! Find out more
BRA

Bender Robert & Associates Portfolio holdings

AUM $417M
1-Year Est. Return 25.02%
This Fund
S&P 500
This Quarter Est. Return
+7.49%
1 Year Est. Return
+25.02%
3 Year Est. Return
+98.12%
5 Year Est. Return
+139.29%
10 Year Est. Return
+812.75%
AUM
$180M
AUM Growth
+$6.46M
Cap. Flow
-$30.8M
Cap. Flow %
-17.07%
Top 10 Hldgs %
57.53%
Holding
51
New
2
Increased
3
Reduced
42
Closed
1

Top Buys

Rank Stock Value
1
CAT icon
Caterpillar
CAT
+$196K
2
DE icon
Deere & Co
DE
+$190K
3
ALXN
Alexion Pharmaceuticals
ALXN
+$52.4K
4
VMW
VMware, Inc
VMW
+$10.1K
5
ADBE icon
Adobe
ADBE
+$2.06K

Top Sells

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$29M
2
CAVM
Cavium, Inc.
CAVM
+$381K
3
KITE
Kite Pharma, Inc.
KITE
+$366K
4
MELI icon
Mercado Libre
MELI
+$217K
5
CELG
Celgene Corp
CELG
+$165K

Sector Composition

Rank Sector Weight
1 Healthcare 31.65%
2 Technology 25.32%
3 Consumer Discretionary 24.58%
4 Communication Services 13.24%
5 Industrials 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.95T
$23.3M 12.91%
550,860
-3,636
-0.7% -$152K
ISRG icon
2
Intuitive Surgical
ISRG
$128B
$13.8M 7.62%
113,091
-231,681
-67% -$29M
ILMN icon
3
Illumina
ILMN
$28.7B
$12M 6.67%
56,663
-364
-0.6% -$74.9K
AMZN icon
4
Amazon
AMZN
$2.49T
$9.87M 5.47%
168,820
-1,900
-1% -$105K
META icon
5
Meta Platforms (Facebook)
META
$1.51T
$9.86M 5.46%
55,847
-171
-0.3% -$30.2K
CELG
6
DELISTED
Celgene Corp
CELG
$8.13M 4.51%
77,912
-1,466
-2% -$165K
MELI icon
7
Mercado Libre
MELI
$92.3B
$6.87M 3.81%
21,840
-804
-4% -$217K
GILD icon
8
Gilead Sciences
GILD
$162B
$6.87M 3.8%
95,834
-208
-0.2% -$15.8K
ULTA icon
9
Ulta Beauty
ULTA
$20.7B
$6.65M 3.68%
29,721
-67
-0.2% -$14.2K
LULU icon
10
lululemon athletica
LULU
$13.4B
$6.49M 3.59%
82,542
-470
-0.6% -$31.3K
CTSH icon
11
Cognizant
CTSH
$22.3B
$6.22M 3.45%
87,642
-445
-0.5% -$32.5K
CAVM
12
DELISTED
Cavium, Inc.
CAVM
$5.95M 3.3%
71,017
-4,931
-6% -$381K
VMW
13
DELISTED
VMware, Inc
VMW
$5.71M 3.16%
45,527
+84
+0.2% +$10.1K
GOOG icon
14
Alphabet (Google) Class C
GOOG
$3.99T
$5.63M 3.12%
107,560
-2,060
-2% -$105K
ABBV icon
15
AbbVie
ABBV
$454B
$5.61M 3.11%
58,023
-468
-0.8% -$44.1K
BKNG icon
16
Booking.com
BKNG
$145B
$4.72M 2.62%
67,900
-25
-0% -$1.81K
VIPS icon
17
Vipshop
VIPS
$7.08B
$4.4M 2.44%
29,359
-131
-0.4% -$1.16K
GOOGL icon
18
Alphabet (Google) Class A
GOOGL
$3.99T
$4.11M 2.28%
78,080
-900
-1% -$46.5K
ADBE icon
19
Adobe
ADBE
$94.5B
$4.08M 2.26%
23,311
+12
+0.1% +$2.06K
SBUX icon
20
Starbucks
SBUX
$118B
$4.04M 2.24%
70,320
-1,502
-2% -$85K
ALXN
21
DELISTED
Alexion Pharmaceuticals
ALXN
$3.93M 2.18%
32,873
+430
+1% +$52.4K
BIDU icon
22
Baidu
BIDU
$35.8B
$3.49M 1.93%
14,898
-173
-1% -$42.3K
PRLB icon
23
Protolabs
PRLB
$1.85B
$3.27M 1.81%
31,752
-230
-0.7% -$20.6K
BIIB icon
24
Biogen
BIIB
$29.5B
$3.02M 1.67%
9,484
-117
-1% -$37.5K
BA icon
25
Boeing
BA
$167B
$1.33M 0.74%
4,528
-28
-0.6% -$7.58K
1
2 3

Similar funds

AWCI
Alpine Woods Capital Investors Purchase, New York $417M AUM 26.83% 1-Year Est. Return
ACM
Alight Capital Management New York $417M AUM 98.18% 1-Year Est. Return
PA
PSI Advisors Tampa, Florida $418M AUM 15.55% 1-Year Est. Return
CEI
Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return
MCM
Millstreet Capital Management Boston, Massachusetts $418M AUM 80.77% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
SCP
Stevens Capital Partners Omaha, Nebraska $416M AUM 18.93% 1-Year Est. Return
VM
Venator Management Pittsburgh, Pennsylvania $416M AUM 16.01% 1-Year Est. Return

Bender Robert & Associates's Q4 2017 Portfolio in Review

As of Q4 2017, Bender Robert & Associates held 51 positions worth $180M, up 3.7% from $174M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Bender Robert & Associates withdrew a net $30.8M in Q4 2017, closing 1 position and reducing 42 holdings. Its most notable exit was Kite Pharma, Inc., an estimated $366K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 35% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Bender Robert & Associates opened a new position in Caterpillar worth $223K.

  • Bender Robert & Associates's largest Q4 2017 buy was Caterpillar: 1,414 shares worth $223K.
  • Bender Robert & Associates added most to Alexion Pharmaceuticals in Q4 2017, an estimated $52.4K increase.
  • Bender Robert & Associates's biggest Q4 2017 reduction was Intuitive Surgical, cutting an estimated $29M.
  • Bender Robert & Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $366K.
  • Bender Robert & Associates's ten largest holdings make up 58% of its $180M portfolio in Q4 2017.
  • Bender Robert & Associates opened 2 new positions and closed 1 in Q4 2017.
  • Bender Robert & Associates's portfolio value rose 3.7% quarter-over-quarter to $180M.

Based on Bender Robert & Associates's 13F filing for Q4 2017, filed 19 Jan 2018.